Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Tania, Tabone"'
Autor:
Nathan T. Harvey, Michael Millward, Benjamin A. Wood, Britt Clynick, Tania Tabone, Katie Meehan, Wendy N. Erber, Kathryn A. Fuller
Publikováno v:
The Journal of Molecular Diagnostics. 17:644-651
In recent years, there has been increasing use of BRAF-inhibiting drugs for the treatment of various malignancies, including melanoma. However, these agents are associated with the development of other nonmelanoma skin lesions, in particular squamopr
Publikováno v:
Pathology. 48(5)
Sebaceous neoplasms encompass a range of lesions, including benign entities such as sebaceous adenoma and sebaceoma, as well as sebaceous carcinoma. The distinction of sebaceous carcinoma from benign lesions relies on histological identification of a
Autor:
Benjamin A. Wood, Kathy Heel, Michael Millward, Wendy N. Erber, Britt Clynick, Tania Tabone, Nathan T. Harvey
Publikováno v:
Journal of Cutaneous Pathology. 42:73-75
Autor:
Diane Wilson, Yan Yan Wang, Tania Tabone, Richard G.H. Cotton, Stephen Tonna, Lin Rigby, Judy Savige
Publikováno v:
Pediatric Nephrology. 23:2201-2207
Thin-basement-membrane nephropathy (TBMN) is characterized by persistent dysmorphic hematuria, and the presence of proteinuria is a risk factor for renal impairment. TBMN is often due to mutations in the COL4A3 and COL4A4 genes, and this study determ
Autor:
Tania Tabone
Publikováno v:
Human Mutation. 29:886-890
The 9th International Symposium on Mutations in the Genome, Mutation Detection 2007, was held on 23–27 September 2007 in Xiamen, China. Meeting participants reported on a broad range of advances in mutation detection technologies and their applicat
The high level of methylguanine-DNA methyltransferase (MGMT) in glioblastoma is responsible for resistance to alkylating agents, such as temozolomide (TMZ). In glioblastomas with a methylated MGMT promoter, MGMT deficiency is presumed, resulting in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2dca962aedd35497568cb63f109bb6
https://europepmc.org/articles/PMC4467216/
https://europepmc.org/articles/PMC4467216/
Autor:
Tania Tabone, Grant Morahan
Publikováno v:
Genes & Immunity. 4:222-227
The cytokine interleukin (IL)-12 is bound by a heterodimeric receptor and mediates a range of immunological activities, in particular, favouring the development of uncommitted T cells to the Th1 phenotype. Genes encoding elements of the IL-12 pathway
Autor:
Britt, Clynick, Tania, Tabone, Kathy, Heel, Wendy, Erber, Benjamin A, Wood, Michael, Millward, Nathan T, Harvey
Publikováno v:
Journal of cutaneous pathology. 42(1)
Autor:
Australian Genomics, Anna K. Nowak, Hazem J. Abuhusain, Tania Tabone, Kerrie L. McDonald, Wendy N. Erber
Publikováno v:
Journal of clinical pathology. 67(7)
Glioblastoma (GBM) is a highly aggressive malignancy and the most effective treatment regime has a high relapse rate. Increasingly, the development of therapies involves defining drug–diagnostic combinations where the presence of a molecular target
Autor:
John P. Newnham, Tania Tabone, O. Brad Spiller, Matthew W. Kemp, Matthew S. Payne, Jeffrey A. Keelan
Publikováno v:
Journal of clinical microbiology. 52(2)
Ureaplasma sp. infection in neonates and adults underlies a variety of disease pathologies. Of the two human Ureaplasma spp., Ureaplasma parvum is clinically the most common. We have developed a high-resolution melt (HRM) PCR assay for the differenti